The Fort Worth Press - Medical Care Technologies (OTC PINK:MDCE) Positions Its Next-Generation AI Strategy Amid Rapid Breakthroughs from NVIDIA and Anthropic

USD -
AED 3.672503
AFN 64.000009
ALL 80.712093
AMD 364.394871
ANG 1.790365
AOA 918.000259
ARS 1524.6764
AUD 1.424207
AWG 1.8
AZN 1.701076
BAM 1.717716
BBD 2.016134
BDT 123.177046
BGN 1.683441
BHD 0.377383
BIF 3014.939006
BMD 1
BND 1.278905
BOB 12.267697
BRL 5.186703
BSD 1.000953
BTN 95.858456
BWP 13.630595
BYN 3.024376
BYR 19600
BZD 2.013235
CAD 1.415295
CDF 2340.000263
CHF 0.830795
CLF 0.024352
CLP 961.549739
CNY 6.71325
CNH 6.714065
COP 3304.75
CRC 455.108332
CUC 1
CUP 24.025823
CVE 96.778865
CZK 21.42195
DJF 178.251648
DKK 6.56825
DOP 59.527678
DZD 133.77999
EGP 51.709801
ERN 15
ETB 162.38462
EUR 0.87864
FJD 2.237195
FKP 0.754816
GBP 0.755285
GEL 2.615009
GGP 0.754816
GHS 11.626559
GIP 0.754816
GMD 73.49826
GNF 8803.600834
GTQ 7.644576
GYD 209.441419
HKD 7.84337
HNL 26.866497
HRK 6.620898
HTG 131.00126
HUF 322.190317
IDR 17976
ILS 3.051398
IMP 0.754816
INR 96.01415
IQD 1311.329993
IRR 1374837.487483
ISK 120.389894
JEP 0.754816
JMD 158.367842
JOD 0.708992
JPY 157.626501
KES 129.610402
KGS 87.448199
KHR 4070.73506
KMF 433.000266
KPW 900.000318
KRW 1362.904979
KWD 0.30881
KYD 0.834171
KZT 443.156186
LAK 22452.716678
LBP 89639.254709
LKR 330.532926
LRD 172.178625
LSL 16.331596
LTL 2.95274
LVL 0.60489
LYD 6.399881
MAD 9.60592
MDL 17.768078
MGA 4419.404276
MKD 54.074585
MMK 2099.83552
MNT 3596.071123
MOP 8.087369
MRU 40.269447
MUR 47.470152
MVR 15.450014
MWK 1735.705221
MXN 17.75037
MYR 4.084597
MZN 63.910078
NAD 16.332887
NGN 1327.861434
NIO 36.833901
NOK 9.51498
NPR 153.367644
NZD 1.764685
OMR 0.384497
PAB 1.000307
PEN 3.398193
PGK 4.459726
PHP 62.494958
PKR 277.376198
PLN 3.843575
PYG 5900.150622
QAR 3.648779
RON 4.636604
RSD 103.147988
RUB 84.147418
RWF 1479.428955
SAR 3.756013
SBD 8.000512
SCR 13.931236
SDG 601.498907
SEK 9.93628
SGD 1.27854
SHP 0.755002
SLE 24.649667
SLL 20969.491881
SOS 572.098558
SRD 37.6675
STD 20697.981008
STN 21.503489
SVC 8.758887
SYP 13002.000254
SZL 16.327731
THB 33.582985
TJS 9.234445
TMT 3.51
TND 2.963376
TOP 2.40776
TRY 48.980703
TTD 6.80881
TWD 31.782502
TZS 2644.984972
UAH 44.823667
UGX 3920.604251
UYU 40.102584
UZS 11846.95307
VES 852.43145
VND 25963
VUV 117.801098
WST 2.745718
XAF 576.350021
XAG 0.016198
XAU 0.000239198684
XCD 2.702551
XCG 1.804034
XDR 0.707052
XOF 576.350021
XPF 104.742206
YER 236.650326
ZAR 16.39065
ZMK 9001.205751
ZMW 19.513758
ZWL 321.999592
SSP 5712.591897
MXV 2.010183
  • RIO

    -0.3300

    97.04

    -0.34%

  • CMSC

    -0.0400

    20.67

    -0.19%

  • RELX

    0.0000

    33.41

    0%

  • RBGPF

    0.0000

    67.95

    0%

  • BCE

    -0.0700

    21.99

    -0.32%

  • BCC

    -0.0300

    75.66

    -0.04%

  • GSK

    0.8600

    51.08

    +1.68%

  • JRI

    -0.0300

    11.52

    -0.26%

  • NGG

    -0.1200

    76.68

    -0.16%

  • CMSD

    0.0900

    20.54

    +0.44%

  • BTI

    -0.0800

    55.75

    -0.14%

  • AZN

    2.0200

    168.1

    +1.2%

  • BP

    -1.4200

    43.16

    -3.29%

  • RYCEF

    0.4600

    19.7

    +2.34%

  • VOD

    0.0700

    17.02

    +0.41%

Medical Care Technologies (OTC PINK:MDCE) Positions Its Next-Generation AI Strategy Amid Rapid Breakthroughs from NVIDIA and Anthropic
Medical Care Technologies (OTC PINK:MDCE) Positions Its Next-Generation AI Strategy Amid Rapid Breakthroughs from NVIDIA and Anthropic

Medical Care Technologies (OTC PINK:MDCE) Positions Its Next-Generation AI Strategy Amid Rapid Breakthroughs from NVIDIA and Anthropic

Rapid advances in artificial intelligence may create new opportunities for MDCE to expand technical capability while accelerating execution across its AI platform initiatives.

Text size:

MESA, AZ / ACCESS Newswire / May 19, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) ("MDCE" or the "Company"), an emerging artificial intelligence and imaging technology company, today announced a strategic evaluation of next-generation AI infrastructure and multimodal vision systems following major advancements from industry leaders NVIDIA and Anthropic that may materially accelerate the Company's AI commercialization roadmap.

Recent breakthroughs in artificial intelligence have materially shifted the competitive landscape.

Anthropic's newly introduced Claude Opus 4.7, capable of processing images up to 2,576 pixels on the long edge-more than 3x prior Claude vision models- alongside major advances in multimodal reasoning, agentic automation, and NVIDIA's next-generation compute infrastructure, may create advanced opportunities for MDCE to dramatically expand technical capabilities without the historical burden of building on foundational infrastructure.

MDCE's AI ecosystem spans consumer, enterprise, and imaging-driven initiatives, including:

  • Preventive health and imaging analysis technologies under development (MDCE Melanoma Scan Beta)

  • Real Game Used - AI memorabilia authentication imaging intelligence (Active)

  • Future enterprise-grade visual intelligence applications (TBA)

  • Snapshot Recipes - AI-powered food recognition, ingredient analysis, and intelligent recipe generation (Live)

For a company focused on imaging analysis, the leap in visual processing capability is particularly meaningful.

Higher-resolution multimodal AI systems may materially enhance object recognition accuracy, scene interpretation, contextual analysis, visual comparison workflows, and enterprise-scale image intelligence-capabilities directly aligned with MDCE's evolving AI pipeline.

This acceleration has prompted management to evaluate whether leveraging newly available AI infrastructure from global technology leaders may create greater shareholder value than certain legacy development pathways conceived prior to the current AI acceleration cycle.

As part of this strategic review, MDCE is also evaluating whether transitioning elements of its existing provisional intellectual property portfolio into non-provisional patent filings remains the optimal path, or whether integrating next-generation commercial AI ecosystems may provide a faster and more capital-efficient route to commercialization.

"AI capabilities have evolved at an extraordinary pace," said Marshall Perkins, CEO of Medical Care Technologies. "When visual AI systems suddenly gain materially stronger image interpretation capabilities and hyperscale infrastructure becomes increasingly accessible, agile companies must reassess execution strategy in real time."

"This is not a defensive adjustment. This is a strategic offensive evaluation designed to align MDCE with the strongest AI infrastructure currently available and accelerate our path toward commercialization, scalability, and shareholder value creation."

About Medical Care Technologies:
 Medical Care Technologies Inc. (OTC Pink:MDCE) is an emerging technology company focused on the development and commercialization of innovative AI-driven applications across lifestyle, wellness, and consumer markets, with Snapshot Recipes representing its first major consumer-facing platform. The company also operates a portfolio of subsidiaries, including Infinite Auctions, an online marketplace specializing in high-end sports memorabilia and collectibles, and Real Game Used (RGU), a proprietary authentication platform leveraging advanced methodologies, including AI-driven image analysis, to verify game-used memorabilia. Through the integration of artificial intelligence, digital platforms, and strategic marketing initiatives, Medical Care Technologies is positioning itself for scalable growth while expanding its presence across both consumer technology and high-value asset markets.

Contact Info:

X account: https://x.com/medicalcaretech
Company Website: https://medicalcaretechnologies.com/

MEDICAL CARE TECHNOLOGIES INC.
1910 S Stapley Drive
Suite 221
Mesa, AZ 85204
[email protected]
+1 480-645-0750

Safe Harbor Statement: This press release contains forward-looking statements, including statements regarding artificial intelligence initiatives, product development, beta technologies, commercialization opportunities, intellectual property strategy, and potential integrations with third-party AI infrastructure. These statements are based on current expectations and involve risks and uncertainties that could cause actual results to differ materially, including technological feasibility, development timelines, regulatory considerations, market conditions, capital availability, competitive factors, commercialization execution, and third-party platform access. References to NVIDIA, Anthropic, or other third-party technologies do not imply partnership or endorsement unless expressly stated. The Company undertakes no obligation to update forward-looking statements except as required by law.

SOURCE: Medical Care Technologies Inc.



View the original press release on ACCESS Newswire

J.Barnes--TFWP